Extending its partnership with provider of cheminformatics software for the lifesciences industry ChemAxon, IDBS has added the Reactor engine, known as the Parallel Synthesis add-on, to support the workflows of chemists, synthesising libraries of compounds in a parallel fashion.
ChemAxon's Reactor is a high performance library enumeration engine which is intended to produce synthetically relevant virtual libraries which should give users an efficient, automated workflow that should save time and improve upon best practices in the lab.
Users of ChemAxon's Reactor are able to draw and edit reactants directly, run and tune reactions to achieve real-world products.
Perrigo to acquire United States rights for Entocort from AstraZeneca
US FDA approves Boehringer Ingelheim's Pradaxa
Phase II clinical trial for potential treatment of androgenetic alopecia completed by Samumed
Life Sciences Partners collaborates on immuno-oncology with Bristol-Myers Squibb
Arsanis initiates first cohort in Phase one clinical trial of ASN100
Impax introduces generic Avodart (Dutasteride) Capsules, 0.5 mg
Mylan unveils generic FazaClo orally disintegrating tablets for treating schizophrenia